Moody’s affirms Bupa Insurance Limited’s Rating

BUPA Finance PLC
10 July 2024

Moody's Ratings affirms Bupa Insurance Limited's A1 Insurance Financial Strength Rating - outlook remains stable


The credit rating agency, Moody's Ratings, has affirmed the A1 insurance financial strength rating of Bupa Insurance Limited, the main UK private medical insurance business and UK operating subsidiary of The British United Provident Association Limited (Bupa).


In the same action, Moody's Ratings affirmed the A3 backed senior unsecured, Baa1(hyb) subordinated and Baa3(hyb) preferred stock non-cumulative debt ratings of Bupa Finance plc, the holding company for all the operating subsidiaries in the Bupa group.


The outlook for both Bupa Insurance Limited and Bupa Finance plc remains stable.


See the full announcement from Moody's here.





Media: Duncan West (Corporate Affairs):

Investors: Gareth Evans (Treasury):


About Bupa


Established in 1947, Bupa's purpose is helping people live longer, healthier, happier lives and making a better world. We are an international healthcare company serving over 50 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers. Bupa has businesses around the world, principally in the UK, Australia, Spain, Chile, Poland, New Zealand, Hong Kong SAR, Türkiye, Brazil, Mexico and India. We also have associate businesses in Saudi Arabia.


For more information, visit




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
UK 100

Latest directors dealings